362 related articles for article (PubMed ID: 15331253)
1. Cancer genetics in primary care.
Culler D; Grimes SJ; Acheson LS; Wiesner GL
Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
[TBL] [Abstract][Full Text] [Related]
2. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
3. [Identification of cancer genes has made the testing of predisposition possible. Genetic counseling and mutation screening can result in new therapeutic methods].
Nordenskjöld M
Lakartidningen; 1999 Aug; 96(32-33):3392-6. PubMed ID: 10479788
[No Abstract] [Full Text] [Related]
4. Psychological impact of genetic testing for cancer susceptibility: an update of the literature.
Meiser B
Psychooncology; 2005 Dec; 14(12):1060-74. PubMed ID: 15937976
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
Prucka SK; McIlvried DE; Korf BR
Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
[TBL] [Abstract][Full Text] [Related]
6. Cancer genetics.
Chapman DD
Semin Oncol Nurs; 2007 Feb; 23(1):2-9. PubMed ID: 17303511
[TBL] [Abstract][Full Text] [Related]
7. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
Shah MR
Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
Metcalfe A; Werrett J; Burgess L; Clifford C
Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.
d'Agincourt-Canning L; Baird P
Crit Rev Oncol Hematol; 2006 May; 58(2):114-23. PubMed ID: 16600617
[TBL] [Abstract][Full Text] [Related]
11. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
12. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
13. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
14. DNA diagnosis and the emergence of cancer genetic services in European health care.
Stemerding D; Koch L; Bourret P
Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191
[No Abstract] [Full Text] [Related]
15. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
16. [Specialized genetic counseling in pediatric and adult oncology patients].
Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2002; 141(1):23-7. PubMed ID: 11899542
[TBL] [Abstract][Full Text] [Related]
17. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
18. Family-based screening for colorectal cancer: The Australian perspective.
Leggett BA
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
[TBL] [Abstract][Full Text] [Related]
19. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
Khabele D; Runowicz CD
Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
[TBL] [Abstract][Full Text] [Related]
20. Genetics and the multidisciplinary breast center.
Peters JA; Rubinstein WS
Surg Oncol Clin N Am; 2000 Apr; 9(2):367-96. PubMed ID: 10757850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
